Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
about
Sesquiterpene lactone in nanostructured parenteral dosage form is efficacious in experimental Chagas disease.Immunomodulatory and Antileishmanial Activity of Phenylpropanoid Dimers Isolated from Nectandra leucantha.Anti-trypanosome effects of nutritional supplements and vitamin D3: in vitro and in vivo efficacy against Trypanosoma brucei bruceiEfficacy of Lychnopholide Polymeric Nanocapsules after Oral and Intravenous Administration in Murine Experimental Chagas DiseaseCoadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.Therapeutical approaches under investigation for treatment of Chagas disease.Nanostructured delivery systems with improved leishmanicidal activity: a critical review.Simple dialkyl pyrazole-3,5-dicarboxylates show in vitro and in vivo activity against disease-causing trypanosomatids.Spectroscopic Study of the Interactions of Ruthenium-Ketoconazole Complexes of Known Antiparasitic Activity with Human Serum Albumin and Apotransferrin.Assessment of sesquiterpene lactones isolated from Mikania plants species for their potential efficacy against Trypanosoma cruzi and Leishmania sp.
P2860
Q33623071-ECD76962-0C78-4FE4-A1FE-ECE1A5A5F298Q36514153-707CF9E3-A5F7-4D75-9B8A-DE58EA7479C6Q37185150-2A6314BF-83DC-4668-B35E-593BB110F5E7Q37203890-02086983-EB49-4F44-BD71-522240D43D89Q37309281-37129516-5903-4E5A-81EA-9EF2072CE25EQ38214136-5306582C-2D55-4622-AA5E-FC1218471C2CQ40099567-7463772B-1F96-472B-ABBF-210053FEAAE3Q40268471-38BCD634-3EE8-42AE-A2C5-76E26BECEC1DQ41849496-4CC60494-A491-4422-AE8C-7F85717394DBQ42370909-5B6B5BDF-D73C-4F97-A097-F79128EF998B
P2860
Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
@en
type
label
Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
@en
prefLabel
Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
@en
P2093
P50
P1476
Innovative lead compounds and formulation strategies as newer kinetoplastid therapies
@en
P2093
P304
P356
10.2174/092986712802884222
P577
2012-01-01T00:00:00Z